During the past decade, Wisconsin Center for Advanced Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 19 clinical trials were completed, i.e. on average, 126.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wisconsin Center for Advanced Research" #1 sponsor was "Pfizer" with 7 trials, followed by "Exact Sciences Corporation" with 6 trials sponsored, "Abbott" with 4 trials sponsored, "Bausch Health Americas, Inc." with 3 trials sponsored and "Evoke Pharma" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wisconsin Center for Advanced Research" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "RTI Health Solutions" with 2 trials as a collaborator and "Aurora Health Care" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Wisconsin Center for Advanced Research" are "Ulcerative Colitis" (16 trials), "Crohn's Disease" (13 trials), "Colorectal Cancer" (5 trials), "Inflammatory Bowel Disease" (4 trials) and "Diabetic Gastroparesis" (3 trials). Many other conditions were trialed in "Wisconsin Center for Advanced Research" in a lesser frequency.

Most popular intervention types in "Wisconsin Center for Advanced Research" are "Drug" (43 trials), "Other" (7 trials), "Biological" (3 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "CP-690,550" (5 trials), "Colonoscopy" (3 trials), "vedolizumab" (3 trials) and "AQUAVAN® (fospropofol disodium) Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wisconsin Center for Advanced Research" are 52 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wisconsin Center for Advanced Research". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in Wisconsin Center for Advanced Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Wisconsin Center for Advanced Research, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".